Review
Open access
Aug 2026
Clinical evidence on non-viral CAR-T cell therapies for solid tumors: a scoping review
Within this limited early-phase evidence base, no severe toxicities attributable to non-viral platforms were reported, and the evidence identifies knowledge gaps warranting prospective investigation.
Favio Varón Suárez, J. Moreno, Oriana Arias-Valderrama et al.
· Frontiers in Immunology · 1 citation